Edgewise Therapeutics
Edgewise Therapeutics is a drug discovery and biotechnology company developing products based on the understanding of skeletal muscle.
3
Funding Rounds
$160.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Al** Ru***** | - | - | - |
| Pe*** Th****** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Al** Ru***** | - | - | - |
| Pe*** Th****** | - | - | |
| Ke*** Ko** | - | - | |
| La*** A. Br*** | - | - | - |
| Ba******* Ed*** | - | - | |
| Jo* Ro** | - | - |
Funding series
Funding Series Analysis
The company Edgewise Therapeutics has raised a total of $15.5m in funding over 3 rounds.
Key Insights:
- Edgewise Therapeutics Series A round, August 2018: $15.5m
- Edgewise Therapeutics funding round, September 2019: $50m
- Edgewise Therapeutics, Inc. funding round, December 2020: $95m
Edgewise Therapeutics Series A round, August 2018
$15.5m
Edgewise Therapeutics funding round, September 2019
$50m
Edgewise Therapeutics, Inc. funding round, December 2020
$95m
Industries
Edgewise Therapeutics is active in the following industries:
- Pharmaceutical industry
- Drug discovery
- Engineering
- Biomedical engineering
- Technology
- Biology
- Biotechnology
- Synthetic chemistry